Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy resTORbio stock
Own resTORbio stock in just a few minutes.
resTORbio, Inc is a biotechnology business based in the US. resTORbio shares (TORC) are listed on the NASDAQ and all prices are listed in US Dollars. resTORbio employs 10 staff and has a market cap (total outstanding shares value) of USD$11.9 million.
How to buy shares in resTORbio
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for resTORbio. Find the stock by name or ticker symbol: TORC. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until resTORbio reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of resTORbio, depending on your broker.
- Check in on your investment. Congratulations, you own a part of resTORbio. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
resTORbio share price
Use our graph to track the performance of TORC stocks over time.resTORbio shares at a glance
Information last updated 2021-01-23.
| 52-week range | USD$0.86 - USD$17.22 |
|---|---|
| 50-day moving average | USD$7.3133 |
| 200-day moving average | USD$2.6582 |
| Wall St. target price | USD$3 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$-1.444 |
Buy resTORbio shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy resTORbio stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
resTORbio financials
| Gross profit TTM | USD$0 |
|---|---|
| Return on assets TTM | -38.47% |
| Return on equity TTM | -66.75% |
| Profit margin | 0% |
| Book value | $1.941 |
| Market capitalisation | USD$11.9 million |
TTM: trailing 12 months
Shorting resTORbio shares
There are currently 560,879 resTORbio shares held short by investors – that's known as resTORbio's "short interest". This figure is 24.7% down from 744,667 last month.
There are a few different ways that this level of interest in shorting resTORbio shares can be evaluated.
resTORbio's "short interest ratio" (SIR)
resTORbio's "short interest ratio" (SIR) is the quantity of resTORbio shares currently shorted divided by the average quantity of resTORbio shares traded daily (recently around 683998.7804878). resTORbio's SIR currently stands at 0.82. In other words for every 100,000 resTORbio shares traded daily on the market, roughly 820 shares are currently held short.
However resTORbio's short interest can also be evaluated against the total number of resTORbio shares, or, against the total number of tradable resTORbio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case resTORbio's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 resTORbio shares in existence, roughly 10 shares are currently held short) or 0.0127% of the tradable shares (for every 100,000 tradable resTORbio shares, roughly 13 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against resTORbio.
Find out more about how you can short resTORbio stock.
resTORbio share dividends
We're not expecting resTORbio to pay a dividend over the next 12 months.
resTORbio share price volatility
Over the last 12 months, resTORbio's shares have ranged in value from as little as $0.86 up to $17.22. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while resTORbio's is 2.433. This would suggest that resTORbio's shares are significantly more volatile than the average for this exchange and represent a higher risk.
resTORbio overview
resTORbio, Inc., a clinical-stage biopharmaceutical company, develops medicine to treat aging-related diseases. Its lead program is selectively inhibits the target of rapamycin complex 1 (TORC1), an evolutionary conserved pathway that contributes to the age-related decline in function of various organ systems, including immune, neurologic, and cardiac functions. The company's lead drug candidate is RTB101, an oral, selective, and potent inhibitor of TORC1 that is in Phase 1b/2a clinical trial for the treatment of Parkinson's disease, as well as to treat neurodegenerative diseases. resTORbio, Inc. has collaboration with TrialSpark to investigate RTB-101 for COVID-19 on the Project Covalence platform. resTORbio, Inc. was founded in 2016 and is headquartered in Boston, Massachusetts.
Frequently asked questions
More guides on Finder
-
How to buy Sigma Labs stock
Steps to owning and managing SGLB, with 24-hour and historical pricing before you buy.
-
How to buy Simpson Manufacturing CoInc stock
Steps to owning and managing SSD, with 24-hour and historical pricing before you buy.
-
How to buy Sequans Communications S-A stock
Steps to owning and managing SQNS, with 24-hour and historical pricing before you buy.
-
How to buy SFL Corporation stock
Steps to owning and managing SFL, with 24-hour and historical pricing before you buy.
-
How to buy Senmiao Technology stock
Steps to owning and managing AIHS, with 24-hour and historical pricing before you buy.
-
How to buy Sensata Technologies Holding stock
Steps to owning and managing ST, with 24-hour and historical pricing before you buy.
-
How to buy Select Bancorp stock
Steps to owning and managing SLCT, with 24-hour and historical pricing before you buy.
-
How to buy Second Sight Medical Products stock
Steps to owning and managing EYES, with 24-hour and historical pricing before you buy.
-
How to buy Sibanye Stillwater stock
Steps to owning and managing SBSW, with 24-hour and historical pricing before you buy.
-
How to buy Shinhan Financial Group CoLtd stock
Steps to owning and managing SHG, with 24-hour and historical pricing before you buy.
Ask an Expert